CP Group distances itself from holy basil patent controversy

Charoen Pokphand Group has issued a statement clarifying its position regarding patent applications connected to holy basil, a herb deeply embedded in Thai culinary and medicinal traditions. The diversified conglomerate emphasized that neither the company nor its leadership bears responsibility for the intellectual property claims, seeking to distance itself from ongoing controversy surrounding the filings.

The move comes as public attention has intensified on efforts to commercialize and patent holy basil, an ingredient central to Thai cuisine and traditional medicine practices. Patent disputes involving culturally significant plants have become increasingly contentious in Thailand, with concerns raised about the appropriation of indigenous knowledge and traditional resources.

CP Group's statement represents an attempt to manage reputational risks associated with the intellectual property matter. The conglomerate, which operates across agriculture, retail, telecommunications, and numerous other sectors, has substantial interests in food and agricultural industries that could be affected by public perception of its involvement in such matters.

The controversy reflects broader tensions in Thailand and across Southeast Asia regarding the commercialization of traditional knowledge and genetic resources. Authorities and civil society organizations have grown more vigilant about protecting culturally significant plants from intellectual property claims that could restrict traditional use or access.